Here are five quick facts:
1. The company’s shares dropped 8.88 percent in the last four weeks.
2. NuVasive shares have underperformed the S&P 500 index by 15.2 percent in the last four weeks.
3. The 52-week high of the share price is $56.61 and the 52-week low is $35.56.
4. The 50-day moving average price is $51.30 and the 200-day moving average price is $49.46.
5. The company has a market cap of $2.3 billion.
More articles on devices:
China spinal fusion market to see double digit growth — 6 points
HSS conducts studies on a new modular partial wrist replacement: 5 takeaways
Wire stimulator technology provides chronic pain relief for San Antonio patients: 4 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
